Metacognitive group therapy for autistic teens with anxiety and depression
Official title: A Metacognitive Group Therapy of Depression and Anxiety in Youth With Autism: Feasibility, Acceptability and Effect in a Clinical Open Trial
Run by Uppsala University · NCT06441786 · Data updated 2026-11-12
This project will try group metacognitive therapy to see if it helps 15–18-year-olds with autism who have anxiety and/or depression.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 15 Years to 18 Years |
| Sex | All |
| Enrollment | 36 (estimated) |
| Sponsor | Uppsala University Academic / other |
| Locations | 1 site (Haninge, Stockholm County) |
| Status | Recruiting |
| Started | August 12, 2024 |
| Main results expected | August 29, 2026 |
| Study ends | August 29, 2026 |
| Registry record updated | September 29, 2025 |
| Trial ID | NCT06441786 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adolescents aged 15–18 with a clinical diagnosis of autism plus anxiety and/or depression who speak Swedish, are seeking care at PRIMA Child and Youth Psychiatry in Handen, and have stable medication and no concurrent psychological treatment are ideal candidates.
✕Probably not a fit
Individuals with bipolar disorder, active substance use or psychosis, high suicide risk or extensive self-harm, those already in or about to start other psychological treatment, or those unable to attend in-person sessions at the study site are unlikely to benefit from or be eligible for this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This open pilot enrolls 15–18-year-olds with autism and anxiety and/or depression into six consecutive group cohorts of six participants each. Groups meet weekly with therapists trained in metacognitive therapy and selected metacognitive processes are monitored at each session. Clinical assessments occur pre-treatment, post-treatment, and at six-month follow-up, and feasibility outcomes include recruitment, retention, compliance, treatment delivery issues, acceptability, and adverse effects. Preliminary symptom and process effects will be analyzed with paired-sample t-tests to inform feasibility and design of future controlled trials.
Why it matters
Potential benefit: If successful, this could reduce anxiety and depression symptoms and improve quality of life and daily functioning for autistic adolescents.
How similar studies have gone: Metacognitive therapy has shown promising results for anxiety and depression in adults but remains relatively untested in adolescents with autism, so this application is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age of 15 to 18 years * Seeking medical care PRIMA psychiatric clinic for children and youth in Stockholm * Diagnoses of anxiety disorder or depression as well as autism established in a clinical interview * Mastering the Swedish language enough to take part of the treatment * Willingness/ability to participate after receiving information about what participation entails Exclusion Criteria: * Assessed to meet one of the following diagnoses: Bipolar syndrome, alcohol use syndrome, substance use syndromes, psychotic symptoms and affective syndromes with psychotic symptoms and antisocial personality disorder. * Assessed to have a high suicide risk. * Assessed to have extensive self-harm behavior or moderate to high risk of such. * Participating in other psychological treatment or about to start such treatment during the time interval of the study. * Has not had stable medication in the last month or is planning a deposit/medication adjustment during the time interval of the study.
Where it's running
-
PRIMA Child and Youth Psychiatry, Handen
Haninge, Stockholm County, Sweden Recruiting
Study contacts
- Principal investigator: Timo Hursti, Ph.D. — Uppsala University
- Study coordinator: Timo Hursti, Ph.D.
- Email: timo.hursti@psyk.uu.se
- Phone: 46 184717842
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Heartsight helps caregivers of kids after cardiac arrest manage uncertainty and fear
This pilot trial tests if the Heartsight information program is acceptable and helpful for caregivers of children who recently had a cardiac arrest.
-
Attachment-Based Compassion Therapy to Prevent Burnout in Spanish Healthcare Professionals
A compassion-based program is tested to see if it can help prevent burnout in Spanish doctors and nurses, compared with a relaxation program.
-
Using a weighted blanket to help cancer patients during IV therapy
A randomized study tests whether wearing a weighted blanket during IV cancer treatment reduces anxiety, stress, and depression and increases comfort compared with standard blankets.
-
Group-based ACT for psychological distress in young people
Researchers are testing whether group-based ACT helps 16-25 year olds with depression or anxiety more than the usual individual therapy.
-
Acupuncture vs Medication for Depression, Anxiety, and Sleep Issues in Chinese Adults
This study tests whether acupuncture can be as effective or more cost-efficient and environmentally friendly than usual medication for reducing depression, anxiety, and sleep problems in adults 18–65 in China.
-
Online group I-Reconstruction psychotherapy to reduce anxiety
This trial tests whether a 10-week online group course using the I-Reconstruction method can help adults with anxiety feel less anxious.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.